![Juha Aimo Koivurinta](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Juha Aimo Koivurinta
Amministratore Delegato presso Fibrogen Europe Oy
Posizioni attive di Juha Aimo Koivurinta
Società | Posizione | Inizio | Fine |
---|---|---|---|
Fibrogen Europe Oy
![]() Fibrogen Europe Oy BiotechnologyHealth Technology Fibrogen Europe Oy develops and markets recombinant human collagens and gelatins for research purposes. It serves companies in the pharmaceutical, vaccine, medical device, diagnostic, industrial, food, cosmetic, and nutraceutical businesses. The company was founded on May 22, 1996 and is located at Helsinki, Finland. | Direttore/Membro del Consiglio | 01/08/2000 | - |
Amministratore Delegato | 01/04/2000 | - |
Storia della carriera di Juha Aimo Koivurinta
Precedenti posizioni note di Juha Aimo Koivurinta
Società | Posizione | Inizio | Fine |
---|---|---|---|
AGC Biologics A/S
![]() AGC Biologics A/S Pharmaceuticals: MajorHealth Technology AGC Biologics A/S provides contract process development and biopharmaceuticals manufacturing services worldwide. It specializes in delivering custom solutions for the scale-up and the cGMP manufacture of protein-based therapeutics for pre-clinical, clinical trials, and commercial production. Its services include cell line development, bioprocess development, formulation, and analytical testing. The company was founded by Peter Vilby, Mads Laustsen, Thomas Sandal, and Morten Munk in 2001 and is headquartered in Soeborg, Denmark. | Direttore/Membro del Consiglio | - | - |
Statistiche
Distribuzione geografica
Danimarca | 2 |
Finlandia | 2 |
Posizioni
Director/Board Member | 2 |
Chief Executive Officer | 1 |
Settori
Health Technology | 3 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Aziende private | 2 |
---|---|
AGC Biologics A/S
![]() AGC Biologics A/S Pharmaceuticals: MajorHealth Technology AGC Biologics A/S provides contract process development and biopharmaceuticals manufacturing services worldwide. It specializes in delivering custom solutions for the scale-up and the cGMP manufacture of protein-based therapeutics for pre-clinical, clinical trials, and commercial production. Its services include cell line development, bioprocess development, formulation, and analytical testing. The company was founded by Peter Vilby, Mads Laustsen, Thomas Sandal, and Morten Munk in 2001 and is headquartered in Soeborg, Denmark. | Health Technology |
Fibrogen Europe Oy
![]() Fibrogen Europe Oy BiotechnologyHealth Technology Fibrogen Europe Oy develops and markets recombinant human collagens and gelatins for research purposes. It serves companies in the pharmaceutical, vaccine, medical device, diagnostic, industrial, food, cosmetic, and nutraceutical businesses. The company was founded on May 22, 1996 and is located at Helsinki, Finland. | Health Technology |
- Borsa valori
- Insiders
- Juha Aimo Koivurinta
- Esperienza